VMLE Veterinary Microbiology Supplemental Materials Notes
I. Immunology
Immunology defined as the study of the immune system and its responses to foreign substances (antigens).
Immunity concepts
Immunity is an enhanced state of responsiveness to a specific substance induced by prior contact with that substance.
Natural (innate) immunity: present from birth, nonspecific. Examples: skin, mucus membranes, macrophages, monocytes, neutrophils, eosinophils, and their products.
Acquired (adaptive) immunity: expressed after exposure to a substance, specific. Two major components:
Humoral immunity (antibody-mediated) by B lymphocytes
Cell-mediated immunity by T lymphocytes
Immune system organization
Central (primary) lymphoid organs: bone marrow, thymus, bursa (in birds)
Peripheral (secondary) lymphoid organs: spleen, lymph nodes, lymphatic channels, tonsils, Peyer’s patches
Principal cells: white blood cells (granulocytes, lymphocytes, monocytes)
Principal molecules: antibodies (immunoglobulins), lymphokines (cytokines produced by lymphocytes), other mediators
Development of the immune system
Maturation of pluripotent stem cells in bone marrow or bursa of Fabricius (birds) into B cells and T cells, with generation of specific surface receptors
B cells: mature in the bursa of Fabricius (birds) or fetal liver/adult bone marrow; generate humoral immunity; surface immunoglobulins (Ig) as antigen recognition receptors; differentiate into antibody-producing plasma cells; localized mainly in germinal centers of lymph nodes and spleen
T cells: mature in the thymus; assist B cells; have T cell receptors (TCRs); mediate cell-mediated immunity; help in suppression of immune responses; majority (~95%) of circulating lymphocytes; reside in paracortical/interfollicular areas of lymph nodes and spleen
Components and cells of the immune system (overview)
Neutrophils, eosinophils, basophils are polymorphonuclear granulocytes
Cytotoxic cells: cytotoxic T lymphocytes (CTLs), natural killer (NK) cells, large granular lymphocytes (LGLs), eosinophils
Complement mainly produced by liver (also by mononuclear phagocytes)
Each cell produces a specific set of cytokines or mediators
D. Physiology of immunity
Activation sequence leading to B cell or T cell activation and antibody production or sensitized T cell generation
Processing (phagocytosis) of antigen by macrophages or B cells, recognition by preformed receptors on B/T cells, blast transformation and clonal expansion to produce plasma cells (antibodies) or sensitized T cells
Origin and development of immune cells
Hematopoietic stem cell differentiation gives rise to all blood/immune cells
Platelets originate from megakaryocytes and circulate
Mononuclear-phagocyte lineage cells arise from blood monocytes
Phagocytosis sequence (example):
Antibody-opsonized bacterium binds Fc receptors on phagocyte
Engulfment to form phagosome
Fusion with lysosomes to form phagolysosome
Killing/digestion of bacterium; bacterial breakdown products presented on macrophage membrane-associated MHC class II for T cell presentation
E. Antigens and epitopes
Antigens: immunogenic molecules that provoke an immune response
Epitope: the specific portion of an antigen recognized by an antibody; antibody-binding site on the antigen
Hapten: a small molecule not immunogenic by itself but can become immunogenic when bound to a larger carrier; hapten-carrier complexes can elicit responses
Antibodies recognize epitopes; antigens may have multiple epitopes; some antigens have repeated epitopes
F. Antibodies (immunoglobulins)
Characteristics: antibodies are gamma-globulin proteins; 7S–19S sedimentation; comprised of heavy (H) and light (L) chains linked by disulfide bonds; at least two identical heavy chains and two identical light chains
Structure: variable regions (V) with hypervariable regions (CDRs) confer antigen specificity; paratope is the antibody’s antigen-binding site, defined by CDRs
Heavy chains: isotypes μ (IgM), δ (IgD), γ (IgG), α (IgA), ε (IgE) with distinct properties
Light chains: κ and λ; contribute to antigen-binding site
IgG (G class): most abundant in serum (~73%), crosses placenta (except IgG4), fixes complement (except IgG4), opsonization and precipitation functions
IgA: monomer in serum, dimer in secretions; protects mucosal surfaces; subtypes IgA1 and IgA2; may include a joining (J) chain and secretory component
IgM: pentamer; large macroglobulin; first Ig to appear in ontogeny and in response to antigen; J chain holds pentamer together; multiple constant domains
IgD: receptor on B cells; minor serum presence; unknown function
IgE: involved in parasitic immunity and type I hypersensitivity; Fc binds basophil/mas cells; associated with Type I hypersensitivity; low serum proportion
Allotypes: minor structural differences within a class/isotype; detectable immunologically
G. Antigen–antibody reactions
Forces holding immune complexes together are protein–protein interactions
Affinity: tendency of one antibody to bind a single epitope with a single antigen
Avidity: cumulative strength of all antibody–epitope interactions with a multi-epitope antigen
Lattice theory: precipitation requires an optimal Ab–Ag ratio; excess of Ab or Ag reduces lattice formation and precipitation
Precipitation tests and related techniques
Ring test: precipitation at Ab–Ag interface
Oudin diffusion (single diffusion): Ab or Ag diffuses through gel to form a precipitate
Ouchterlony (double diffusion): agar gel allows Ag and Ab to diffuse; interpret lines of identity, non-identity, and partial identity
Immunoelectrophoresis (IEP): resolves complex Ag–Ab mixtures
Rocket immunoelectrophoresis: rapid estimation of antigen concentration
Radial immunodiffusion: antigen concentration estimation
Radioimmunoassay (RIA): radioactively labeled antigen to quantify antigen/antibody
ELISA: enzyme-labeled antibody; colorimetric readout; intensity proportional to antigen amount
H. Immunocompetent cells in the immune response (APCs and lymphocytes)
Antigen-presenting cells (APCs): macrophages, monocytes, dendritic cells, Langerhans’ cells; high antigen-processing capacity; express Ia (MHC II) antigens, Fc receptors, C3b receptors; produce IL-1
T cells: thymus-derived; TCR with CD markers; CD4+ (helper); CD8+ (cytotoxic/suppressor); CD3 associated with TCR; regulate and execute cell-mediated responses
B cells: develop in bone marrow; surface Ig receptor; differentiate into plasma cells; respond to antigen exposure with antibody production
Ontogeny: B-cell lineage; T-cell lineage; CD markers progression (CD2, CD3, CD4, CD8, etc.)
I. Initiators of the immune response
T-dependent antigens: require APCs, helper T cells, lymphokines to activate B cells to produce antibodies; dominant initiation type
T-independent antigens: do not require helper T cell activity; polymeric in nature; produce primary IgM response; no immunologic memory or robust secondary (IgG) response; examples include endotoxin, LPS, dextran, polymerized flagellin, EBV
J. Histocompatibility Antigens (MHC) and T-cell interactions
MHC I (HLA class I): expressed on nearly all nucleated cells; present endogenous antigens to CD8+ Tc cells
MHC II (HLA class II): expressed on APCs; present exogenous antigens to CD4+ helper T cells
Immunologic role: T cells recognize antigens only in the context of appropriate MHC molecules
H. Tumor Immunology
Tumor cells express tumor-associated antigens (TAAs)
Immune mechanisms against tumors involve both humoral and cell-mediated responses; antibodies may contribute to tumor destruction; cell-mediated immunity (e.g., CTLs) plays a major role
K. Complement System
Complement-mediated cytotoxicity can lyse target cells
Activation pathways: Classical (IgG/IgM dependent) and Alternative (e.g., LPS, endotoxin, zymosan) pathways
Functions: lysis of target cells; opsonization to enhance phagocytosis; recruitment of inflammatory cells; increased blood flow and vascular permeability; mediators can activate mast cells
J. Hypersensitivity Reactions (Gell and Coombs classification)
Type I: Immediate hypersensitivity (anaphylaxis)
Mediated by IgE bound to mast cells/basophils; allergen cross-linking triggers mediator release
Systemic or localized; examples: insect venom, penicillin, pollen
Measurement: RIST or RAST (IgE testing)
Type II: Cytotoxic reactions
Antibody directed against cell-surface epitopes causing cell destruction (complement-mediated lysis or antibody-dependent cellular cytotoxicity)
Examples: transfusion reactions (ABO incompatibility), autoimmune hemolytic anemia, Goodpasture’s syndrome, myasthenia gravis
Type III: Immune complex (hypersensitivity) reactions
Soluble antigen–antibody complexes deposited in tissues; complement activation; neutrophil recruitment; inflammation
Examples: Arthus reaction, farmer’s lung, serum sickness, rheumatoid arthritis
Type IV: Delayed-type hypersensitivity (cell-mediated)
Mediated by T cells (Th1 and CD8+ cytotoxic T cells) with cytokines; not antibody-mediated
Sequence: antigen uptake by macrophages; presentation to Th cells; Th activation; lymphokine production; macrophage activation and cytotoxic responses
Key cytokines and mediators: IL-1, IL-2, TNF, MAF, MCF, HRF, etc.
L. Autoimmune and Developmental Immunologic Disorders
Developmental disorders: e.g., dysgammaglobulinemia, congenital thymic aplasia (DiGeorge), Wiskott–Aldrich syndrome (X-linked; thrombocytopenia, eczema, infections), SCID
Autoimmune disorders: immune regulation failure leading to host tissue attack
Theories: molecular mimicry; exposure of sequestered self-antigens; altered self-molecules; hapten-carrier effects; loss of suppressor cell function
Systemic autoimmune diseases: SLE (autoantibodies, immune complex disease, nephritis), rheumatoid arthritis (RF, joint destruction), polyarteritis nodosa; SLE features also include vasculitis and neuropsychiatric manifestations
Organ-specific autoimmune disorders: myasthenia gravis (anti-ACh receptor), autoimmune thyroiditis (thyroglobulin/thyroid microsomes), Graves’ disease (TSH receptor antibodies), type 1 diabetes (islet cell antibodies)
M. Interferons, Cytokines, and Mediators of Inflammation
Interferons (IFN-α, IFN-β, IFN-γ) and cytokines with diverse roles in antiviral defense and immune regulation
Cytokine table highlights major interleukins (IL-1, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10) and tumor necrosis factor (TNF) with their cellular sources and actions (T cells, macrophages, endothelial cells, dendritic cells, etc.)
Mechanisms of interferon action: IFN produced by virus-infected cells induces resistance to viral replication in neighboring cells; IFN-γ activates macrophages and enhances antigen presentation; cytokines modulate T cell responses and B cell differentiation
N. Types of Vaccines
Active immunization involves administering antigen(s) to elicit an immune response and resistance
Herd immunity concept: a proportion of immune individuals in a population provides protection to others by reducing transmission
Ideal vaccine properties: prolonged, robust immunity; minimal adverse effects; cost-effective; stable; suitable for mass vaccination; vaccines that distinguish from natural infection (DIVA capability)
Vaccines containing replicating antigens
Attenuated (live-attenuated) vaccines: reduce virulence so organisms replicate but remain avirulent; examples include certain rinderpest, canine distemper (historical); risks include reversion to virulence; rigorous stability testing required; modern molecular methods improve stability
Gene-deleted vaccines: remove virulence genes (e.g., thymidine kinase in pseudorabies); retain immunogenicity with reduced virulence; may block latent infection; used to improve safety and DIVA capabilities
Live vectored vaccines: protective genes inserted into avirulent vectors (e.g., poxviruses such as fowlpox, canarypox, vaccinia); provide strong immunity and DIVA; no shedding in some wildlife vaccination programs; examples include vaccines for avian influenza, canine distemper, rabies, West Nile virus; vector safety and host-restriction features are important
Vaccines with non-replicating or killed antigens (killed vaccines): generally safer but less immunogenic; adjuvants are often required
Subunit vaccines: use purified components (e.g., tetanus toxoid) or purified antigenic structures (pili) to elicit immunity; recombinant subunits for E. coli enterotoxin shown as example
Adjuvants: boost immune response, essential for killed/subunit vaccines
Depot adjuvants (alum, aluminum salts): slow antigen release; can cause local reactions
Particulate adjuvants (emulsions, liposomes, ISCOMs): enhance delivery to APCs; variable adoption in veterinary vaccines
Immunostimulants (BCG, CpG DNA, saponins): stimulate cytokine production and APC activation
Immunostimulants: non-antigen-dependent immune enhancement; used in chronic immunosuppressive conditions; examples include BCG
Non-replicating antigen vaccines: include killed organisms and subunits; often require adjuvants for strong responses
DIVA (Distinguishing Infected from Vaccinated Animals): vaccines designed with markers to differentiate infection from vaccination status
Summary of I section
Immunology integrates cellular/molecular components, antigen recognition, and immune effector mechanisms
The immune system is organized into specialized anatomical compartments and uses a suite of cells and molecules to recognize and respond to pathogens, with a balance between protective immunity and the risk of hypersensitivity or autoimmunity
II. Virology
Historical background and milestones
Edward Jenner (1798): smallpox vaccine (cowpox origin)
Louis Pasteur (1885): first rabies vaccine; father of microbiology/virology
Iwanowski and Beijerinck (1892): filtration experiments leading to concept of viruses; TMV discovery
Beijerinck (1898): term "virus" (Latin for poison)
Twort & D’Herelle (1922): bacteriophages
Stanley (1935): viruses contain nucleic acid and protein
Enders, Weller, Robbins: replication of poliovirus in cell culture
Baltimore, Dulbecco, Temin: RNA and DNA viruses replication strategies
Montagnier (1984): discovery of HIV; Prusiner (1986): prions
Ellerman and Bang (1908): Avian leukemia virus
Parts of a virus
Viral genome (DNA or RNA; single- or double-stranded; linear or circular; sense + or -)
Capsid: protein coat protecting genome; composed of capsomeres; symmetry can be helical, icosahedral, cubic, or complex; functions include genome delivery and antigenicity
Nucleocapsid: capsid plus enclosed genome
Viral envelope (enveloped viruses): lipid bilayer with glycoprotein spikes (peplomers), matrix protein; fusion proteins; envelope mediates receptor binding and entry
Lipids and lipoproteins of envelope derived from host cells
Virion: complete infectious particle
Viroid: virus-like nucleic acid only (plants)
Prions: infectious protein with no nucleic acid
Origins of viruses
Regressive theory: viruses evolved from cellular parasites that lost cellular features
Subcellular element theory: derived from cellular genetic material that gained independence
Methods of viral diagnosis
Virus isolation: sensitive but slow; may not work for non-viable viruses
Direct observation by electron microscopy: rapid; detects non-viable viruses; equipment-intensive
Serologic identification of virus/antigen: rapid; gives serotype information; interpretation may be complex
Nucleic acid probes (PCR-based): rapid, sensitive; broad applicability; risk of contamination
Recognition of cellular pathology by light microscopy: rapid but limited to certain infections
Antibody detection: retrospective outbreak correlation; may be slow
Virulence, host resistance, and genetics
Virulence: measure of pathogenicity; virulent strains not always highly transmissible; high transmission not always high virulence
Genetic determinants: genome composition, gene reassortment, mutation, recombination, etc.
Pathways of replication: lytic vs lysogenic; attachment and entry (tropism); uncoating; replication; assembly; release
Viral replication and pathogenesis (summary)
Attachment and entry via specific cellular receptors; enveloped viruses enter by fusion or receptor-mediated endocytosis; naked viruses may enter by endocytosis
Two major replication pathways: Lytic (cell lysis and virion release) and Lysogenic (latent infection; genome persistence with limited expression)
Virus-induced changes in cells: cytocidal (cytopathic effects) versus noncytocidal; transformation can lead to oncogenesis in some viruses
Modes of viral dissemination within the host: local spread, viremia, systemic infection
Major virus families and representative diseases (high-level overview)
Parvoviridae: small, non-enveloped ssDNA; stable; causes feline panleukopenia, canine parvovirus; fetal/necrotic effects
Adenoviridae: dsDNA; canine infectious hepatitis; kennel/canine diseases; various species
Herpesviridae: enveloped DNA viruses; latent infections; bovine infectious bovine rhinotracheitis, feline herpesvirus, canine herpesvirus
Poxviridae: largest DNA viruses; enveloped; go in various animals; features include pocks and skin lesions
Circoviridae: small, non-enveloped ssDNA; porcine circovirus 2 (PCV2) with PMWS
Iridoviridae/Chirroviridae/Circoviridae: examples and host ranges listed in notes
Retroviridae: RNA viruses; lentiviruses (FIV), gammaretroviruses (FeLV), etc.; potential oncogenesis
Orthomyxoviridae (influenza): segmented RNA genome; H (hemagglutinin) and N (neuraminidase) surface proteins; antigenic shift and drift
Paramyxoviridae: Nipah, Henipavirus concerns in humans/animals; Newcastle disease; canine distemper; measles-like viruses in animals
Rhabdoviridae: rabies virus; vesicular stomatitis virus
Filoviridae: Ebola, Marburg; high mortality
Reoviridae/Arenaviridae/Bunyaviridae/Coronaviridae: various animal and human pathogens
Suggested specimens for virus isolation
Chicken embryo (10–12 days) and inoculation routes: chorioallantoic membrane, yolk sac; embryo age matters for tropism
III. MICROBIOLOGY
A. Biochemical test for identification of bacteria
Milestones in antimicrobial therapy are discussed in context of microbiology techniques
Key test categories include carbohydrate fermentations, enzymatic activities, amino acid decarboxylation, urease, gelatin hydrolysis, hippurate hydrolysis, indole production, citrate utilization, malonate, VP test, and others
Examples of test media/indicators: Aesculin, Edward’s medium, SIM (sulfide, indole, motility), TSI (triple sugar iron), CTA sugars, MIO, ribose/galactose tests, oxydase, catalase
B. Anatomy and cell envelope of Gram-negative Enterobacteriaceae (illustrative)
Outer membrane with LPS; periplasmic space; peptidoglycan; cytoplasmic membrane; O-antigen repeats
Major genera referenced: Citrobacter, Enterobacter, Escherichia, Klebsiella, Morganella, Proteus, Providencia, Salmonella, Serratia, Shigella, Yersinia
C. Major families and notable pathogens (conceptual overview)
Enterobacteriaceae: pathogenesis and identification strategies
Pasteurellaceae, Moraxellaceae, Haemophilus, Actinobacillus, Clostridia, Streptococci, Staphylococci, and other veterinary pathogens
D. Immunological and antigenic tests (summary)
Agglutination-based and immunological tests used to characterize bacterial isolates
Coagulase tests, urease tests, indole tests, oxidase tests, citrate utilization tests, and others used in routine labs
E. Meat hygiene and microbial risk assessment (highlights)
Ante-mortem examination; post-mortem inspection; condemnations; hold as suspect; pass for slaughter; etc.
HACCP (Hazard Analysis Critical Control Points): identify hazards, CCPs, critical limits, monitoring, deviations, verification, and record-keeping
Microbiological considerations for meat quality and safety; SPC (standard plate count) as a general index of contamination
F. Food-borne pathogens and meat/dairy safety (key examples and context)
Staphylococcal food poisoning (enterotoxins) from S. aureus; rapid onset
Salmonellosis (Salmonella spp.) with enteric and septicemic forms; antibiotic use considerations
Escherichia coli pathotypes (ETEC, EIEC, EPEC, EHEC) and their clinical implications, including hemolytic uremic syndrome with E. coli O157:H7
Zoonoses such as Listeriosis (Listeria monocytogenes); Brucellosis; Leptospirosis; Psittacosis; Campylobacter spp.; Brucella spp.
Dermatophytes (dermatophytosis) in animals and humans; Aspergillosis; Candidiasis; other fungal infections; yeasts and molds in dairy/meat contexts
Protozoa like Toxoplasma gondii; Trichinella spp. in meat; parasitic zoonoses in food chains
G. Principles of meat product safety and quality assessment
Species-specific differences in meat color, fat content, fiber structure, and odor; processing considerations for different meats (beef, carabeef, pork, poultry, etc.)
Milk and dairy safety: composition, pasteurization methods (LTH, HTST, UHT); whey and byproducts; milk components (casein, lactalbumin, lactose, minerals); off-flavors and their sources; milk quality indicators (mastitis tests, acidity, clotting tests, alcohol test)
Food preservation basics: chemical preservatives, heat treatment, canning, dehydration, smoking, fermentation; effect of pH on heat treatments; microbiological spoilage controls
H. Veterinary microbiology reference tables (selected concepts)
Summary of key biochemical tests and results used to differentiate bacteria (e.g., indole, citrate, malonate, MIO, beta-hemolysis, etc.)
Pathogen profiles for major veterinary bacteria (Staphylococcus spp., Streptococcus spp., Pasteurella spp., Mannheimia spp., Haemophilus spp., Listeria spp., Clostridium spp., Bacillus spp., Erysipelothrix spp., Nocardia, Actinomyces, Bacteroides, Fusobacterium, Campylobacter, Brucella, Leptospira, Salmonella, Escherichia)
Common viruses and viral diseases with veterinary impact (species- and host-specific summaries)
IV. ZOONOSES
Definition and scope
Zoonoses are diseases transmitted naturally between vertebrate animals and humans; infections shared between animals and humans; definitions per World Health Organization
A. Types by reservoir and life cycle
Anthropozoonoses: disease of animals transmitted to humans
Zooanthroponoses: disease of humans transmitted to animals
Amphixenoses: maintained in both humans and animals
Orthozoonoses (direct zoonoses): direct transmission (e.g., rabies)
Cyclozoonoses: require more than one vertebrate host to complete life cycle (e.g., Toxoplasmosis)
Metazoonoses: transmitted by invertebrate vectors where the agent multiplies (e.g., Rift Valley fever)
Saprozoonoses: require both a vertebrate host and an environmental reservoir (soil, water) (e.g., Anthrax)
B. Groups at risk
Group I–VII cover agricultural workers, abattoir workers, wildlife handlers, public health professionals, and emergency workers
C. Viral zoonoses (selected groups)
Poxviridae, Herpesviridae, Togaviridae, Flaviviridae, Bunyaviridae, Orthomyxoviridae, Paramyxoviridae, Picornaviridae, Rhabdoviridae, Reoviridae, Filoviridae, Arenaviridae, Coronaviridae, etc.
Highlighted zoonotic viruses and notable pathogens: Nipah, Hendra, Ebola/Marburg, Rift Valley fever, Japanese encephalitis, West Nile, Avian influenza, Rabies, Psittacosis (Chlamydia psittaci), etc.
D. Bacterial zoonoses (selected examples)
Leptospirosis (Leptospira interrogans): multiple serovars; zoonotic; signs range from fever to hepatic/renal involvement; transmission via urine-contaminated water
Brucellosis (Brucella spp.): Malta fever; abortion in animals; occupational exposure in humans
Anthrax (Bacillus anthracis): cutaneous, inhalational, gastrointestinal forms; environmental spore persistence
Tetanus (Clostridium tetani): wound infections; neurotoxin-mediated
Botulism (Clostridium botulinum): neurotoxin-mediated; foodborne but also animal forms
Staphylococcal intoxication; Salmonellosis; E. coli diarrhea; Zoonotic tuberculosis (Mycobacterium bovis, etc.); Streptococcosis; Pasteurellosis; Listeriosis; Psittacosis
E. Fungal zoonoses
Dermatophytosis (ringworm): Trichophyton, Microsporum, Epidermophyton; zoonotic transmission between animals and humans
Aspergillosis: predominantly pulmonary; zoonotic risk in immunocompromised or highly exposed individuals
Candidiasis: opportunistic infections; common in humans and animals under immunosuppression
F. Parasitic zoonoses
Taeniasis/Cysticercosis (Taenia spp.); Echinococcosis (Echinococcus granulosus/multilocularis); Paragonimiasis (lung fluke); Schistosomiasis (Schistosoma spp.)
Transmission routes include ingestion of undercooked meat, waterborne exposure, and snail/soil vectors
G. Protozoonoses
Toxoplasmosis (Toxoplasma gondii): cats as definitive hosts; major fetal risk; immunocompromised individuals at risk
H. Prions (as zoonotic concern)
Subacute spongiform encephalopathies; BSE, Scrapie; Kuru, Creutzfeldt–Jakob disease in humans; transmission routes and public health considerations
V. FOOD HYGIENE
A. Microorganisms in food
Molds, yeasts, bacteria constitute food microbiology concerns
Fermentation, spoilage, and safety considerations rely on controlling microbial growth
B. Classification of bacteria by temperature tolerance
Thermophiles, mesophiles, psychrophiles, psychrotrophs; implications for storage and spoilage
C. Meat hygiene
Ante-mortem examination; post-mortem inspection; reinspection; slaughter; stunning; meat inspection
Emergency and hot meat concepts; downer animals; reactor status (Mallein, Brucellosis tests)
Bacteriological exam: SPC and detection of pathogens
Species meat differences and quality assessment (color, fat, texture, odor)
D. Ante- and post-mortem disease considerations
Diseases during ante-mortem and post-mortem; signs; condemnation criteria
E. Meat refrigeration and processing
Chilling (<15°C for beef; <7°C for lamb; <10°C for pork) within specified times to avoid cold shortening
Freezing at -18°C or lower; issues like freezer burn and drip loss; thawing strategies
F. Fish hygiene
Fresh, frozen, and processed fish classifications; freshness tests (TMA, VA, pH); bacteria monitoring; irradiation and packaging concerns
G. Milk hygiene
Milk composition and dairy products; pasteurization methods (LTH 63°C 30 min; HTST 72°C 15 s; UHT 135–150°C for 1–4 s)
Milk quality tests; mastitis tests (Strip Cup, CMT); acidity and clotting tests
Off-flavors sources and prevention; keeping quality indicators
H. Food preservation
Types of spoilage (chemical vs microbial); methods of preservation including asepsis, removal of microorganisms, drying, heat, irradiation, cold storage, modified atmospheres
Food additives and preservatives: organic acids, nitrates/nitrites, sulfur dioxide, sorbents; sugar and salt effects; smoking; curing; antimicrobial residue considerations
I. Cleaning and sanitation
Cleaning vs sanitation; water quality (hard vs soft); detergents; sanitizers; disinfection options (halogens, quats, phenolics); sanitizer effectiveness depends on concentration, contact time, microbial load, and compatibility with materials
J. HACCP (Hazard Analysis Critical Control Points)
HACCP as preventive food safety framework; steps include assembling team, describing product, identifying hazards, establishing CCPs, critical limits, monitoring, deviation procedures, verification, and record-keeping
K. Epidemiology in food safety context
Hazard analysis, risk assessment, and outbreak investigation integration into food safety systems
VI. EPIDEMIOLOGY
A. Introduction and definitions
Etymology: epi- on/above; demos- people; logos- study
Study of disease in populations; distribution and determinants of disease frequency in man
B. Historical developments
Hippocrates; Fracastorius; Thomas Sydenham; John Graunt; John Snow; foundational thinkers in epidemiology
C. Epidemiologic approaches
Descriptive vs analytic; ecological (medical ecology); etiologic epidemiology; herd health/preventive medicine; clinical epidemiology
Shoe-leather epidemiology: field outbreak investigations
D. Concept of cause and disease etiology
Cause: necessary vs sufficient conditions; web of causation (multiple factors—agent, host, environment)
Risk factors: elements increasing disease risk
E. Types of etiologic and ecological factors
Agent factors (virulence, pathogenicity, etc.); host factors (genetic susceptibility, age, sex, breed); environmental/managing factors (climate, husbandry, etc.)
Horizontal vs vertical transmission; vectors (mechanical vs biological)
Host categories and ecological concepts (definitive, intermediate, reservoir, etc.)
F. Epidemiologic approaches and study designs
Observational: descriptive, cross-sectional, case-control, cohort (prospective/retrospective); analytical vs descriptive aims
Interventional: field and clinical trials
Theoretical: mathematical modeling
Shoe leather approach to outbreak investigations
G. Measures of disease frequency
Vital statistics: crude birth rate, general fertility rate, crude death rate
Morbidity/mortality measures: attack rate, incidence rate, prevalence rate, case fatality rate
Attack rate: typically defined as the number of new cases in a defined population at risk during a short period divided by the number at risk at the start, often expressed as a percentage
Incidence rate: new cases during a time period divided by the population at risk during that period
Prevalence: existing cases at a point in time divided by the population at risk at that time
Case fatality rate: deaths due to a specific disease divided by total cases of the disease
Formulations (LaTeX):
Attack rate: ext{Attack Rate} = rac{A}{N} imes 100 ext{ ext{%}} where A = number of new cases, N = population at risk
Relative risk (RR):
Odds ratio (OR): often used in case-control studies; defined as for a 2x2 table
Attributable risk (AR):
Population attributable risk (PAR): and Population attributable fraction:
H. Patterns of disease occurrence
Sporadic: rare, irregular occurrence
Endemic: disease occurs with predictable regularity in a population
Hyper-, holo-, meso- and hypoendemic levels describe disease burden across populations
Epidemic: frequency clearly in excess of expected; Pandemic: widespread across regions/countries
I. Outbreak investigation framework
Descriptive phase: pattern discovery in time, place and person; epidemic curve; geographic mapping; demographic profiling
Analytic phase: testing hypotheses against data; identify risk factors, sources, transmission pathways
Intervention/plan: measures to contain the outbreak and protect populations
J. Transmission dynamics and ecology
Transmission mechanisms: horizontal (direct or indirect via fomites); vertical (congenital, transplacental, transmammary)
Factors affecting spread: host susceptibility, contact rate, agent stability outside the host, vector presence
Vectors: mechanical vs biological; vector types and roles in disease spread
K. Ecological and environmental determinants
Physical environment (topography, climate, shelter, soil)
Biological environment (plants, animals, humans)
Spatial distribution and clustering as clues to etiology
Cartographic mapping types (spot maps, grid maps, isodemic/isopleth overlays, computer-generated maps)
L. Population and sampling concepts
Population size determination (census, sampling methods)
Sampling techniques: probability sampling (simple random, stratified, systematic, multistage) vs non-probability sampling (convenience, accidental, quota, purposive)
Sampling error and how to reduce it (increasing sample size, better design)
Population indices: line transects, etc.
M. Surveillance, surveys, and study types
Surveillance: ongoing data collection for health status monitoring
Surveys: cross-sectional health status Snapshots; used for outbreak detection and prevalence estimates
Case-control and cohort studies, case reports/series, clinical trials, randomized controlled trials
N. Diagnostic test evaluation concepts
Precision (repeatability) and accuracy (validity)
Sensitivity: true positive rate; specificity: true negative rate
False positive rate (FPR) and false negative rate (FNR)
Predictive values: positive predictive value (PPV) and negative predictive value (NPV)
Gold standard concept for comparison
Formulas (LaTeX):
Sensitivity:
Specificity:
False positive rate:
False negative rate:
PPV:
NPV:
O. Other epidemiology concepts
Strength of association: relative risk, odds ratio, correlation coefficient
Study design quality indicators and interpretation of results
Phases of pandemic (WHO framework, 2009 revision): Phase 1 through Phase 6, with Phase 4 indicating verified human-to-human transmission and community-level outbreaks, Phase 5 indicating spread to another country/region, Phase 6 indicating global pandemic status
Herd immunity considerations; vaccination strategies; outbreak response planning
P. Environmental and risk assessment frameworks
Ecological and environmental determinants; the role of climate, seasonality, and geography in disease distribution
Cartographic tools and GIS-based thinking to map risk and track outbreaks
LaTeX-formatted equations and key concepts recap
Antibody–antigen binding concepts:
Affinity: the tendency of an antibody to bind to a single epitope on an antigen, i.e., Ab-epitope specificity
Avidity: the overall strength of binding between an antibody and a multivalent antigen
Immune testing and interpretation:
Sensitivity and specificity definitions and their impact on diagnostic decisions
Predictive values depend on disease prevalence in the population being tested
Vaccine-related concepts:
DIVA: marker-based differentiation of infected vs vaccinated animals
Herd immunity thresholds depend on vaccine efficacy and coverage
Population disease measures:
Attack rate: the proportion of at-risk individuals who become cases during an outbreak
Relative risk: comparison of disease incidence between exposed and unexposed groups
Attributable risk and population-attributable risk quantify how much of the disease burden is attributable to a risk factor and how much could be prevented by removing the risk factor in a population
Summary and study-friendly takeaways
Immunology basics are foundational for understanding host–pathogen interactions, vaccine design, and hypersensitivity.
Virology covers virus structure, replication, diagnostics, and how viruses cause disease in animals; knowledge of replication strategies informs antiviral approaches and vaccine development.
Microbiology literacy (bacteria, fungi, parasites) underpins diagnosis, infection control, food safety, and pharmacology.
Zoonoses emphasize the One Health concept: animal health, human health, and environmental health are interconnected; surveillance and prevention in animals can prevent human disease.
Food hygiene and HACCP are practical frameworks for ensuring food safety from farm to fork; understanding microbiology and sanitation practices reduces spoilage and disease risk.
Epidemiology provides tools to quantify disease in populations, assess risk factors, evaluate interventions, and guide public health decisions; test characteristics (sensitivity, specificity) and measures (RR, AR, PAR, PAF) are essential for interpreting diagnostic tests and intervention impact.
The content integrates theory with practical examples: diagnostic tests, vaccine strategies (live-attenuated, vectored, subunit), meat/milk safety, outbreak investigations, and zoonotic disease management in veterinary contexts.
If you’d like, I can tailor these notes into a shorter pocket study sheet or expand any section with more detailed sub-points and example questions for exam practice.